Skip to content

Effects of Differences in Body Composition on Retina and Choroid

The Impact of Changes in Body Composition on the Retina and Choroid

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06888765
Enrollment
261
Registered
2025-03-21
Start date
2024-07-01
Completion date
2025-01-01
Last updated
2025-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Body Composition, Obesity, Obesity, Morbid

Keywords

Obesity, Retina, Choroid, Body Mass Index (BMI), Body Composition Analysis, Optical Coherence Tomography (OCT), Microvascular Structures

Brief summary

The goal of this observational study is to examine the effects of body composition differences on retinal and choroidal structures. The study aims to investigate how variations in fat distribution and body composition parameters influence ocular microvascular structures. The main questions it aims to answer are: * How do differences in body composition (BMI, waist circumference, bioelectrical impedance parameters) affect retinal and choroidal microvascular structures? * Are there significant structural changes in the retina and choroid among individuals with different body composition profiles? Participants will: * Be classified into five groups based on their Body Mass Index (BMI) (underweight, normal weight, overweight, obese, and severely/morbidly obese). * Undergo detailed body composition analysis using bioelectrical impedance analysis (BIA) to assess fat mass, muscle mass, visceral fat index, and metabolic age. * Receive comprehensive ophthalmologic evaluations, including Optical Coherence Tomography (OCT) and Optical Coherence Tomography Angiography (OCTA), to measure retinal thickness, choroidal thickness, and microvascular parameters. * OCTA images will be analyzed using the OCTAVA software to compute vascular parameters. This study does not involve any new treatments, drugs, or interventional procedures. The findings aim to provide insights into the relationship between body composition and ocular microvascular health, contributing to early detection and prevention strategies for obesity-related ocular complications.

Detailed description

Study Overview This study is a prospective observational research planned to be conducted at Düzce University between July 1, 2024, and October 1, 2024. The aim of this study is to evaluate the potential effects of body composition differences on retinal and choroidal microvascular structures using non-invasive imaging techniques. The study is designed to investigate how obesity-related changes in fat distribution, metabolic parameters, and vascular structures may influence ocular health. A total of 200 participants are planned to be enrolled, consisting of individuals who will visit the ophthalmology clinic for routine eye examinations and will be confirmed to have no pre-existing ocular pathologies. Participants will be classified into five groups based on Body Mass Index (BMI): * Group 1: Underweight (BMI \<18.5) * Group 2: Normal weight (BMI 18.5-24.9) * Group 3: Overweight (BMI 25-29.9) * Group 4: Obese (BMI 30-34.9) * Group 5: Severely/Morbidly Obese (BMI \>35) Each group is expected to include 40 participants. Planned Study Procedures and Measurements Ophthalmologic Evaluations All participants will undergo a comprehensive ophthalmologic examination, including: * Autorefractometry to assess refractive errors * Intraocular pressure (IOP) measurement using a non-contact tonometer * Detailed slit-lamp biomicroscopy to examine anterior and posterior segment structures Body Composition Analysis * Bioelectrical Impedance Analysis (BIA) will be performed to assess: * Total body fat percentage, visceral fat index, muscle mass, and metabolic age * Segmental body composition (fat and muscle mass in arms, legs, and trunk) * Extracellular and intracellular water distribution * Waist circumference, waist-to-hip ratio, waist-to-height ratio OCT and OCTA Imaging * Optical Coherence Tomography (OCT) and Enhanced Depth Imaging-OCT (EDI-OCT) will be used to obtain: * Macular and peripapillary retinal thickness measurements * Retinal nerve fiber layer (RNFL) thickness * Optic disc and cup-to-disc ratio analysis * Choroidal thickness at the subfoveal region and 500 µm intervals * Optical Coherence Tomography Angiography (OCTA) will be performed to analyze: * Superficial and deep retinal capillary plexus vascular density * Foveal avascular zone (FAZ) area, perimeter, and circularity * Vascular tortuosity and branchpoint density Image Processing and Analysis * OCTA images will be analyzed using the OCTAVA software, where: * Vessel area density, vessel length density, total vessel length, mean vessel diameter, median vessel diameter, branchpoint density, fractal dimension, and vessel tortuosity will be calculated. * FAZ metrics (FAZ area, perimeter, and circularity) and vascular density values will be evaluated using ETDRS grid segmentation and FD-300 analysis. * Choroidal Vascularity Index (CVI) will be calculated from EDI-OCT images using ImageJ software. Study Objectives and Clinical Significance This study aims to determine the relationship between body composition differences and retinal/choroidal microvascular changes to better understand how systemic metabolic alterations influence ocular structures. The results are expected to contribute to: * Identifying early ocular biomarkers associated with obesity * Developing preventive strategies for obesity-related retinal and choroidal complications * Enhancing the clinical use of non-invasive imaging techniques in metabolic disease monitoring No new treatment, drug, or interventional procedure is planned to be applied in this study, and no life-threatening risks are anticipated.

Interventions

OTHEROptical Coherence Tomography (OCT) and Body Composition Analysis

This observational study included non-invasive diagnostic assessments to evaluate retinal, choroidal, ocular, and body composition parameters. Optical Coherence Tomography (OCT) measured macular and peripapillary retinal parameters, including retinal volume and cup/disc ratio. Enhanced Depth Imaging OCT (EDI-OCT) assessed choroidal thickness and vascularity, while Optical Coherence Tomography Angiography (OCTA) analyzed vessel density and foveal avascular zone (FAZ) metrics. Optical biometry measured axial length, anterior chamber depth, lens thickness, K1, K2, and central corneal thickness. Autorefractometry and tonometry were part of the routine ophthalmologic examination, including slit-lamp biomicroscopy. Bioelectrical impedance analysis (BIA) assessed body composition, including BMI, fat percentage, muscle mass, and metabolic age. These assessments were for research purposes only, without therapeutic intervention.

Sponsors

Bayram Meydan
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Age between 18 and 65 years, * No detected pathology in routine ophthalmologic examination, * Providing written informed consent for participation.

Exclusion criteria

* Presence of ocular diseases such as glaucoma, uveitis, diabetic retinopathy, amblyopia, or retinal vein occlusion, * History of previous ocular surgery, * Refractive error exceeding ±4 diopters, * Use of medications that may affect choroidal or retinal vascular structures, * Pregnancy or breastfeeding, * Presence of metallic prostheses, pacemakers, or other implants that could interfere with body composition analysis.

Design outcomes

Primary

MeasureTime frameDescription
Peripapillary Retinal Nerve Fiber Layer (RNFL) ThicknessBaseline (Cross-sectional)Measurement of peripapillary RNFL thickness in micrometers using spectral-domain OCT. RNFL thickness is assessed around the optic disc at baseline.
Choroidal Vascularity Index (CVI)Baseline (Cross-sectional)Calculation of the choroidal vascularity index (CVI) as the ratio of luminal area to total choroidal area in EDI-OCT images. Measurements are performed at the subfoveal region and analyzed using ImageJ software.
Retinal Microvascular Parameters (OCTA)Baseline (Cross-sectional)Evaluation of retinal microvascular parameters using Optical Coherence Tomography Angiography (OCTA). Metrics include vascular density, vessel length, and foveal avascular zone (FAZ) area/circularity in both superficial and deep capillary plexuses.
Central Macular Thickness (CMT)Baseline (Cross-sectional)Measurement of central macular thickness (CMT) in micrometers using spectral-domain Optical Coherence Tomography (OCT). The measurement focuses on the 1 mm central foveal region.
Choroidal ThicknessBaseline (Cross-sectional)Subfoveal choroidal thickness (in micrometers) measured using Enhanced Depth Imaging OCT (EDI-OCT). Measurements are taken at the fovea and at predefined intervals (e.g., 500 µm, 1000 µm) on either side of the fovea.

Secondary

MeasureTime frameDescription
Composite Regional Vascular Density Changes in Retinal and Choroidal LayersBaselineThis composite outcome measure evaluates retinal and choroidal vascular densities (VAD, VLD) in predefined ETDRS regions (foveal, parafoveal, perifoveal) using OCTA. The objective is to compare these densities across different BMI groups.
Composite Association Between Body Composition and Ocular ParametersBaselineThis composite outcome measure includes correlation analyses between BIA parameters (fat percentage, muscle mass, visceral fat, metabolic rate) and multiple ocular structures (central macular thickness, RNFL thickness, choroidal thickness, CVI). The aim is to determine whether body composition influences overall microvascular integrity.

Other

MeasureTime frameDescription
FAZ AreaBaselineMeasurement of the foveal avascular zone (FAZ) area (in mm²) using OCT Angiography to evaluate differences across BMI groups.
Body Composition AnalysisBaselineThis outcome measure involves the analysis of body composition parameters using bioelectrical impedance analysis (BIA) with the Tanita BC-418 MA device. Parameters such as body weight, body mass index (BMI), total fat percentage, muscle mass, visceral fat, and basal metabolic rate are recorded. These data are compared across different BMI groups to evaluate overall body composition differences.
FAZ PerimeterBaselineMeasurement of the FAZ perimeter (in mm) using OCT Angiography to assess potential variations in foveal microcirculation among different BMI categories.
FAZ Circularity IndexBaselineAssessment of FAZ shape using a circularity index. Higher values indicate a more circular FAZ. Comparisons will be made across underweight, normal, overweight, obese, and severely obese groups.
Axial LengthBaselineComparison of axial length measurements among different BMI categories to identify possible associations with ocular morphology.
Autorefraction MeasurementsBaselineSpherical equivalent refraction (in diopters) measured using an autorefractometer. Differences across BMI categories will be assessed.
Intraocular Pressure MeasurementsBaselineIntraocular pressure (IOP) measured in mmHg using a non-contact tonometer. Differences across BMI groups will be evaluated.
Anthropometric Measurements (Waist, Hip, and Height)BaselineThis outcome measure includes the measurement of waist circumference, hip circumference, and height. From these, waist-to-hip ratio (WHR) and waist-to-height ratio (WHtR) are calculated to assess central obesity. All measurements are performed following standardized protocols at baseline.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026